Kapila v. Warburg Pincus, LLC (In re Universal Health Care Group, Inc.)

560 B.R. 594
CourtUnited States Bankruptcy Court, M.D. Florida
DecidedMay 9, 2016
DocketCase No. 8:12-bk-1520-KRM; Jointly Administered with Case No. 8:13-bk-5952-KRM; Adv. No. 8:15-ap-132-KRM
StatusPublished
Cited by1 cases

This text of 560 B.R. 594 (Kapila v. Warburg Pincus, LLC (In re Universal Health Care Group, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kapila v. Warburg Pincus, LLC (In re Universal Health Care Group, Inc.), 560 B.R. 594 (Fla. 2016).

Opinion

MEMORANDUM OPINION AND ORDER ON DEFENDANTS’ MOTIONS TO DISMISS

K. Rodney May, United States Bankruptcy Judge

The debtor, Universal Health Care Group (“Universal”), was a holding company whose subsidiaries offered regulated Medicare HMO plans in Florida, Texas and Nevada. In February of 2013, the State of Florida commenced insolvency proceedings against the two Florida subsidiaries for lack of capital. Universal filed for Chapter 11 relief on February 6, 2013, before the UCC sale of the subsidiaries’ stock by the group of senior secured creditors, led by BankUnited. Universal attempted a § 363 sale of the subsidiaries, but that effort failed. The Court then directed the appointment of a trustee.

The Chapter 11 trustee, Soneet Kapila (the “Trustee”), filed this adversary proceeding alleging that Universal’s collapse is the result of its borrowing $37.5 million in 2011 to redeem preferred stock at a [596]*596price of $33 million. The Trustee seeks to avoid the redemption payments and recover damages from the defendants, each of whom have filed motions to dismiss.1

FACTUAL BACKGROUND .

The Court takes the allegations in the complaint as true, and summarizes the pertinent allegations below.2

Universal was a Delaware corporation headquartered in St. Petersburg, Florida (¶ 12).3 It was formed by a merger in 2006. It offered health insurance and managed care products through wholly-owned, regulated subsidiaries (¶ 12).

One of the Florida subsidiaries, Universal Health Care, Inc. (“UHC”), had contracts with the Department of Health and Human Services and the Center for Medicare and Medicaid Services (“CMS”), to provide health care services to Medicare enrollees in Florida (¶ 12). The other Florida subsidiary, Universal Health Care Insurance Company (“UHCIC”), had contracts with CMS to provide Medicare services to enrollees in twenty-three states and the District of Columbia (¶ 12). Universal also had regulated Medicare HMO subsidiaries in Texas and Nevada (¶ 12). A fifth subsidiary, debtor American Managed Care, LLC (“AMC”), operated as a third-party administrator for the regulated subsidiaries (¶ 12).

Akshay M. Desai, M.D. (“Dr. Desai”), was Universal’s CEO and Chairman (¶ 13). Universal’s largest shareholders were Dr. Desai and the Desai Limited Partnership, an entity controlled by Dr. Desai and his wife (¶ 13). Dr. Desai was the indirect majority shareholder through his control of the Desai Limited Partnership (¶ 29). He also led Universal’s management team (If 29).

On May 26, 2006, Universal entered into Stock Purchase Agreements with defendants Allen Wise (“Wise”) and Warburg Pincus Private Equity IX, LP (“Equity IX”), a private fund organized and managed by defendant Warburg Pincus, LLC (“Warburg”) (¶¶ 4 and 18).4 Equity IX and Wise agreed to purchase 11,143,871 and 384,271 shares, respectively, of Universal’s Series A Convertible Preferred Stock (the “Preferred Stock”) (¶¶ 21 and 22).

In anticipation of the stock purchase, Equity IX loaned Universal $6.2 million (¶ 19). On August 18, 2006, Equity IX can-celled the $6.2 million note and invested another $22,660,471, bringing its total investment in Universal to $28,860,471 (¶¶ 19 and 21). In return, it received 11,143,871 shares of the Preferred Stock (¶ 21). The invested funds were earmarked as working capital (¶ 21). Contemporaneously, Wise invested $1,000,000, in return for 384,271 shares of the Preferred Stock (¶ 22).

Universal filed an Amended and Restated Certificate of Incorporation (“COI”) in Delaware on August 17, 2006 (¶ 20). The COI provided the holders of the Preferred [597]*597Stock with a right of redemption, exercisable after five years (i,e., in August of 2011) at a formula price (Ex. B § 10 (a)). •

Equity IX and Wise, as holders of the Preferred Stock, had: (a) a first claim to Universal’s equity value; (b) the right to receive quarterly dividends (in the form of additional shares of Preferred Stock or cash); and (c) the right to compel Universal to repurchase the’ Preferred Stock on or after August 17, 2011 (¶ 26). If Equity IX and Wise had elected to redeem their shares in August 2011, the combined price required by the COI would have been approximately $60 million (¶ 28).5

The Stock Purchase Agreement also required placement of at least one of War-burg’s investment professionals on Universal’s board of directors, in keeping -with Warburg’s general policy for its private equity funds (¶ 24). This allowed Warburg to monitor its investments for the benefit of its investors (¶ 24).

Defendant Alok Sanghvi (“Sanghvi”) became Warburg’s representative on Universal’s Board in 2008 (¶ 23). Sanghvi was an employee of Warburg, having the status of “principal” (¶¶ 6 and 23). He remained on Universal’s board until February 15, 2011 (¶¶ 6 and 69). Warburg maintained control over decisions and actions of Sanghvi with respect to Equity IX and Universal'(¶ 6).

Equity IX and Wise did not own a majority stake in Universal; nor did they control its operations (¶ 29). But, the Stock Purchase Agreement gave Warburg and Equity IX veto power over certain matters, including (a) selling, leasing, or disposing of asséts in excess of $1.0 million outside the ordinary course of business and (b) incurring indebtedness for borrowed money in excess of $1.0 million in any fiscal year (¶ 25).

The business of the regulated subsidiaries was dependent on Medicare funding levels, which were susceptible to fluctuations based on changes in reimbursement rates authorized by CMS (¶ 14). Universal’s financial condition was deteriorating between 2007 and 2011 (¶¶ 40 and 52-57):

a. UHC had experienced a deterioration in the level of medical claims payable in the last six months of 2006; the ratio of medical claims to premium income had risen and UHC had un-derpriced its products;
b. the medical loss ratio projected for UHCIC was 99%; medical losses were expected to almost equal premium income;
c. 1st Quarter 2007 earnings, before depreciation, interest, taxes, depreciation and amortization (“EBITDA”), was a negative $18.3 million;
d. by early 2007, Universal was in a “zone of insolvency;”
e. in 2007, the State of Florida Office of Insurance Regulation demanded evidence of an adequate capital structure, and forwarded a proposed order of liquidation; and
f. in 2007, the State of Florida Office of Insurance Regulation commenced litigation. concerning capitalization and liquidation of UHCIC.

Universal’s financial projections were erroneous, including inaccurate EBITDA, which painted a healthier picture of Universal’s financial condition than actually existed (¶¶ 51, 52 and 62). Universal’s projections of net income in 2008, 2009 and 2010 were also erroneous (¶ 57). EBITDA [598]*598fell during 2008 by $44,000,000, increased in 2009 by $10,000,000, and fell again in 2010 by $4,500,000 (¶ 52). Net income followed a similar trend; so did cash (¶ 53).

Universal’s auditors, Ernst & Young, LLP (“E & Y”), published an audited consolidated financial report for Universal for the year 2007, showing cash of $245 million and net income of $43 million (¶ 38).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
560 B.R. 594, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kapila-v-warburg-pincus-llc-in-re-universal-health-care-group-inc-flmb-2016.